| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.093 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |